Liquid Dosage

Oncology

As a result of growing competition and more stringent regulatory requirements for end-user safety, improving the convenience and ease of administration of parenteral therapeutics is becoming a common strategy for biotechnology and pharmaceutical companies. Manufacturers wishing to gain market share and provide high quality products for healthcare professionals and cancer patients alike are increasingly investing in the development and delivery of liquid dosage forms, freeze-dried products and injectables.

Pharmaceutical Development

GEA is known all over the world for its individual and tailor-made process plant for the manufacture of free-flowing pharmaceutical and biotechnology products. Complete plant, modular equipment, process units and skids can be assembled, tested and qualified in our own production facilities. We perform tests and trial runs with appropriate media to demonstrate the functionality of all components and equipment before the plant is delivered.

In collaboration and partnership with our customers, we aim to develop and deliver high-performance plant and economic process systems that comply with the highest operational safety and environmental standards; we want our customers to use our groundbreaking solutions to manufacture even better products in the future.

GEA can supply a specialized, contained and fully integrated system when no standard off-the-shelf one exists, particularly for toxic or highly potent drugs such as cytostatics or echo contrast media. With our innovative ideas and fresh approaches, together with your project team, we will find a solution that’s tailored to your needs — from basic engineering to fabrication and qualification.  

Downloads

GEA Insights

Innovating patient care with aseptic spray drying

At GEA, our commitment to engineering for a better world fuels our pursuit of innovative solutions that enhance patient care and safety. One of our most promising ventures in recent years is aseptic spray drying – a technology...

Young people enjoying a beer together

Cambio de fermentación: Tres claves para un futuro brillante para los cerveceros

Las empresas cerveceras que se vuelvan más flexibles, sostenibles y digitales podrán adaptarse más fácilmente al cambiante mercado de la cerveza.

Lecitina: Cuando un subproducto se cuela en el papel principal

La lecitina ocupa un lugar especial en el pensamiento del responsable de ventas de productos GEA, Patrick Schürmann. Esta versátil sustancia ha pasado de tener una función secundaria a ser la estrella del mercado del refinado...

Recibir noticias de GEA

Mantente al día de las innovaciones e historias de GEA suscribiéndote a las noticias GEA.

Contacta con nosotros

¡Estamos aquí para ayudar! Con solo un poco de información podremos responder tu consulta.